Genetic Modification of Human Hematopoietic Cells: Preclinical Optimization of Oncoretroviral-mediated Gene Transfer for Clinical Trials
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
This chapter provides information about the oncoretroviral transduction of human hematopoietic stem/ progenitor cells under clinically applicable conditions. We describe in detail a short -60 h transduction protocol which consistently yields transduction efficiencies in the range of 30-50% with five different oncoretroviral vectors. We discuss a number of parameters that affect transduction efficiency, including the oncoretroviral vector characteristics, the vector stock collection, the source of CD34+ cells and transduction conditions.
References
1.
Veena P, Traycoff C, Williams D, McMahel J, Rice S, Cornetta K
. Delayed targeting of cytokine-nonresponsive human bone marrow CD34(+) cells with retrovirus-mediated gene transfer enhances transduction efficiency and long-term expression of transduced genes. Blood. 1998; 91(10):3693-701.
View
2.
Deola S, Scaramuzza S, Birolo R, Carballido-Perrig N, Ficara F, Mocchetti C
. Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice. Hum Gene Ther. 2004; 15(3):305-11.
DOI: 10.1089/104303404322886156.
View
3.
Gaspar H, Parsley K, Howe S, King D, Gilmour K, Sinclair J
. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet. 2004; 364(9452):2181-7.
DOI: 10.1016/S0140-6736(04)17590-9.
View
4.
Lu L, Xiao M, Clapp D, Li Z, Broxmeyer H
. High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood. J Exp Med. 1993; 178(6):2089-96.
PMC: 2191297.
DOI: 10.1084/jem.178.6.2089.
View
5.
Sanyal A, Schuening F
. Increased gene transfer into human cord blood cells by centrifugation-enhanced transduction in fibronectin fragment-coated tubes. Hum Gene Ther. 1999; 10(17):2859-68.
DOI: 10.1089/10430349950016582.
View